Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Cash Flow Statement
Cash Flow Statement
Bellevue Life Sciences Acquisition Corp
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
1
|
|
| Cash from Operating Activities |
(0)
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-680%
|
(1)
-38%
|
(1)
-52%
|
(1)
+1%
|
(2)
-132%
|
(2)
-5%
|
|
| Investing Cash Flow | |||||||||||
| Other Items |
0
|
0
|
0
|
(70)
|
(70)
|
(70)
|
(34)
|
36
|
53
|
53
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
(70)
N/A
|
(70)
N/A
|
(70)
+0%
|
(34)
+52%
|
36
N/A
|
53
+47%
|
53
0%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
64
|
64
|
73
|
37
|
(27)
|
(44)
|
(53)
|
|
| Net Issuance of Debt |
1
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
2
|
|
| Other |
(1)
|
(0)
|
(1)
|
7
|
7
|
(2)
|
(1)
|
(9)
|
(9)
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
0
-14%
|
0
+100%
|
71
+58 733%
|
71
0%
|
71
+0%
|
35
-51%
|
(36)
N/A
|
(51)
-44%
|
(51)
+0%
|
|
| Change in Cash | |||||||||||
| Net Change in Cash |
0
N/A
|
0
-17%
|
0
+140%
|
0
+183%
|
(0)
N/A
|
(0)
+79%
|
(0)
-561%
|
(0)
-212%
|
0
N/A
|
(0)
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(0)
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-680%
|
(1)
-38%
|
(1)
-52%
|
(1)
+1%
|
(2)
-132%
|
(2)
-5%
|
|